Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Year: 2021
Type: review
Source: Nature Reviews Urology
Authors: Elaine Chang, Andrea B. Apolo, Rick Bangs, Stephanie Chisolm, Vinay Duddalwar, Jason A. Efstathiou, Kirsten B. Goldberg, Donna E. Hansel, Ashish M. Kamat, Paul G. Kluetz, Seth P. Lerner, Elizabeth Plimack, Tatiana Prowell, Harpreet Singh, Daniel Suzman, Evan Y. Yu, Hui Zhang, Julia A. Beaver, Richard Pazdur, Chana Weinstock, Matthew D. Galsky
Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research, National Cancer Institute, Center for Cancer Research, Bladder Cancer Advocacy Network, University of Southern California, Massachusetts General Hospital, Oregon Health & Science University, The University of Texas MD Anderson Cancer Center, Baylor College of Medicine, Fox Chase Cancer Center, University of Washington, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3196747859